Prediction of future risk of any and higher-grade prostate cancer based on the PLCO and SELECT trials.

Jonathan A GelfondBrian HernandezMartin GorosJoseph G IbrahimMing-Hui ChenWei SunRobin J LeachMichael W KattanIan M ThompsonDonna Pauler AnkerstMichael Liss

Published in: BMC urology (2022)

A 1- to 5-year PCa risk prediction model developed from PLCO and SELECT was validated with SABOR and implemented online. This model can individualize and inform shared screening decisions.

Keyphrases

prostate cancer
radical prostatectomy
social media
current status
health information
healthcare